Monday, June 22, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 557 of 1,261

  1. US 10010612

    Sustained delivery formulations of risperidone compounds

    Indivior UK Limited · Granted Jul 3, 2018 · Expires Jun 28, 2038

    granted

  2. US 10010648

    Transdermal delivery system

    FIRST WATER LIMITED · Granted Jul 3, 2018 · Expires Jun 28, 2038

    granted

  3. US 10010629

    Compositions and methods for in vivo imaging

    The Regents of the University of California · Granted Jul 3, 2018 · Expires Jun 28, 2038

    granted

  4. US 10010595

    Live recombinant booster vaccine against tuberculosis

    The Regents of the University of California · Granted Jul 3, 2018 · Expires Jun 28, 2038

    granted

  5. US 10010571

    Nutritional supplement for the enhancement of muscle irisin and enhancement of brown fat, metabolic rate, and weight loss, and methods of use thereof

    Maximum Human Performance, LLC · Granted Jul 3, 2018 · Expires Jun 28, 2038

    granted

  6. US 10010573

    Engineered rice having alcoholism relief and liver protection function, and preparation method thereof

    CHINA NATIONAL RESEARCH INSTITUTE OF FOOD & FERMENTATION INDUSTRIES CO., LTD. · Granted Jul 3, 2018 · Expires Jun 28, 2038

    granted

  7. US 10010567

    Bioeffective krill oil compositions

    AKER BIOMARINE ANTARCTIC AS · Granted Jul 3, 2018 · Expires Jun 28, 2038

    granted

  8. US 10010508

    MTAB-TA-Coated gold nanorods and method of fabrication

    United States of America as represented by the Secretary of the Air Force · Granted Jul 3, 2018 · Expires Jun 28, 2038

    granted

  9. US 10010523

    Short acting phenylalkylamine calcium channel blockers and uses thereof

    Milestone Pharmaceuticals Inc. · Granted Jul 3, 2018 · Expires Jun 28, 2038

    granted

  10. US 10011574

    Glutaminase inhibitors and method of use

    Agios Pharmaceuticals, Inc. · Granted Jul 3, 2018 · Expires Jun 28, 2038

    granted

  11. US 10010522

    Short acting phenylalkylamine calcium channel blockers and uses thereof

    Milestone Pharmaceuticals Inc. · Granted Jul 3, 2018 · Expires Jun 28, 2038

    granted

  12. US 10010524

    Short acting phenylalkylamine calcium channel blockers and uses thereof

    Milestone Pharmaceuticals Inc. · Granted Jul 3, 2018 · Expires Jun 28, 2038

    granted

  13. US 10010534

    Intravenous formulation and LC/MS/MS analysis method for GMC1

    The Board of Regents of the University of Texas System · Granted Jul 3, 2018 · Expires Jun 28, 2038

    granted

  14. US 10010525

    Methods of inducing anesthesia

    The Regents of the University of California · Granted Jul 3, 2018 · Expires Jun 28, 2038

    granted

  15. US 10011588

    1,2-substituted cyclopentanes as orexin receptor antagonists

    Takeda Pharmaceutical Company Limited · Granted Jul 3, 2018 · Expires Jun 28, 2038

    granted

  16. US 10010599

    Norovirus vaccine formulations

    Takeda Vaccines, Inc. · Granted Jul 3, 2018 · Expires Jun 28, 2038

    granted

  17. US 10005743

    Methods for producing viloxazine salts and novel polymorphs thereof

    Supernus Pharmaceuticals, Inc. · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted

  18. US 10006052

    Laglidadg homing endonuclease cleaving the C-C chemokine receptor type-5 (CCR5) gene and uses thereof

    PRECISION GENOME ENGINEERING, INC. · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted

  19. US 10004704

    Compositions and methods for treating chronic inflammation and inflammatory diseases

    Infirst Healthcare Limited · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted

  20. US 10004702

    Linear guanidine derivatives, methods of preparation and uses thereof

    LEAD DISCOVERY SIENA S.R.L. · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted

  21. US 10004782

    Glucokinase activator compositions for the treatment of diabetes

    VTV THERAPEUTICS LLC · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted

  22. US 10005735

    Inhibitors of RPN11

    The Regents of the University of California · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted

  23. US 10005740

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted

  24. US 10005771

    Bicyclic derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities

    Almirall, S.A. · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.